Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
LNSR
STRONG SELLLENSAR, Inc. · Healthcare · United States · $69M · Avg Vol: $475K/d
11
StockRankGet insider-trade alerts
Q
45
V
30
M
13
P/E (TTM)
—
ROE
362.5%
D/E
0.1x
Dividend %
—
Loading 1Y...
PRICE (1Y)-7.7%
SMA 50SMA 200
Close
$5.37
RSI (14)
18.9
52W High
$13.31
From 52W High
0.4%
SCORE BREAKDOWN
Quality
45
ROIC
-53.6%14.1
ROE
362.5%99.9
GP/Assets
36.9%77.3
Op. Margin
-15.9%27.9
FCF/Assets
-20.9%17.6
Piotroski
111.4
Int. Cover
—N/A
D/E Ratio
0.10x62.2
Current Ratio
2.38x45.1
Value
30
P/E (TTM)
—N/A
EV/EBITDA
-3.4x25.0
P/FCF
—N/A
P/B
6.3x21.3
P/S
1.2x80.5
Div Yield
—N/A
Momentum
13
52W High %
40%16.2
RS 6M
-65%7.2
SMA 50/200
0.65x5.5
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
-29%12.4
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$69M
P/E (Forward)
-7.9x
Gross Margin
45.7%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of LNSR are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| LNSR | LENSAR, Inc.(you) | $69M | 11 | STRONG SELL |
| OM | Outset Medical, Inc. | $75M | 16 | STRONG SELL |
| HYPR | Hyperfine, Inc. | $95M | 13 | STRONG SELL |
| SERA | Sera Prognostics, Inc. | $80M | 5 | STRONG SELL |
| COCH | Envoy Medical, Inc. | $51M | 14 | STRONG SELL |
| LDX.AX | Lumos Diagnostics Holdings Limited | $75M | 3 | STRONG SELL |
| MDAI | Spectral AI, Inc. | $52M | 16 | STRONG SELL |
| ARAY | Accuray Incorporated | $53M | 18 | STRONG SELL |
| LUNG | Pulmonx Corporation | $53M | 18 | STRONG SELL |
| CVRX | CVRx, Inc. | $126M | 12 | STRONG SELL |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.6%